In the course of isolation of a bioactive component from the culture broth of a Streptomyces, strain SF-973, we encountered an unusual phenomenon. Although a bioactive substance could be extracted with ethyl acetate under alkaline condition, solvent extraction resulted in a considerable loss of the total bioactivity originally found in the culture filtrate. However, when the aqueous layer and the solvent extract were combined, most of the antibiotic activity of the original broth was recovered. This phenomenon was explained as synergistic action of two biologically inactive substances, i.e. SF-973 B, a large molecular compound which remained in the aqueous layer, and SF-973 G, a small molecular compound which was solvent-soluble. This strain also produced the third component (SF-973 A) as a minor component which in Japan. Important characteristics of this strain were summarized in Table 1 , and, based on the taxonomic study, the organism was namedStreptomyces olivaceus SF-973 by the The reaction was carried out at 30°C/ One unit of the enzymatic activity was denned as the amount that induces an increase in the absorbancy at 290my of 0.001 in one minute under the above condition.
MethodB: Since dihydroabikoviromycin (II) or SF-973 B alone shows no antibacterial property,, the enzymatic activity of SF-973 B could be indirectly estimated by the antibiotic activity of I formed from II as the dehydrogenation proceeds. Klebsiella pneumoniae was used asa test organism, and a paper disc plate methodwas employed. To the mediumconsisting of 1.0% glucose, 0.5% NaCl, 0.3% K2HPO4, 0.02% MgSO4-7H2O, 0.1% NH4H2PO4 and 1.5 % agar (pH 7.0), compound II was added in the concentration of lOOmcg/ml. After spraying the test organism, a paper disc dipped in solution containing SF-973 B was put on the plate and incubated at 28°C for 20hours.
The content of SF-973 B in a test sample was assayed from the inhibition diameter* relative to that of the standard SF-973 B with the highest purity so far obtained. This, method has an advantage of simpler operation than Method A and preferably was used in collected, dissolved in 1 liter of 0.01M borate buffer (pH 6.8) and was dialyzed against 0.01m borate buffer (pH 6.8) for 24hours. The dialyzed solution (1.8 liters, pH 6.6) was loaded on a column of DEAE-cellulose (10x14cm) which was equilibrated with 0.01M borate buffer of pH 6.5. After washing with 1 liter of 0.01M borate buffer (pH 6.5), the column was eluted with 0.1m borate buffer (pH 9.0). The activity of SF-973 B was assayed by Method B, and a chromatographic pattern was shown in Fig. 1 . The active fractions (Fract. vol. 4,000-5,800ml, 1,800 ml) were combined and ammo- was charged to a column of Sephadex G-100 (1,700ml), which was equilibrated with the buffer solution as described above and developed with the same buffer, fractionating in 20 ml. The representative chromatographic pattern is illustrated in Fig. 2 . By this procedure, a great majority of inert protein and polysaccharide contaminants were removed. The fractions containing the enzyme SF-973 B (Fract. vol. 840-1,300 ml) were collected (460 ml), concentrated to about 10 ml by the Diaflow filration method, and re-chromatographed over Sephadex G-100 (400 ml). The chromatographic condition was the same as that described above, and 18-ml fractions were collected.
As shown in Fig. 3 , good correlation was observed between the activity and protein peaks. Active fractions (Fract. vol. 210~280ml, 70ml) free of impure peaks were collected and concentrated to about 20ml by the Diaflow filtration method. The concentrate was dialyzed with a Visking cellophane tube and freezed dry. The SF-973 B preparation thus obtained was a white powder (80mg), and 120-fold more potent than that of the first ammoniumsulfate precipitate. This final preparation of SF-973 B was not a completely pure enzyme but further purification was difficult due to a very low production of the enzyme in the culture broth. The specific activity of the final preparation was 18,200u/mg N. On cellulose acetate electrophoresis in 0.1 M tris buffer at pH 8.0, SF-973 B migrated 1.3 cm toward an anode under the electric current of 1.5mA/cm for 1 hour. Spots were visualized by staining with amido black or nigrosin, and two minor extra bands were observed in addition to a main band of SF-973 B. After 30minutes, the spot of II disappeared completely and a single bioactive spot of Rf 0.5 was observed. The incubated solution was extracted with ethyl acetate at pH 9, and the solvent layer was washed with water, and then reextracted with acidified water (pH 3 by sulfuric acid). Ethyl-ether extraction of the aqueous layer at pH 9 and addition of sulfuric acid gave 30mg of the crystalline sulfate. This was identified as abikoviromycin by comparison of UV, NMRand antibacterial spectrum1). In a blank experiment, compound II or SF-973 B alone was incubated, but no formation of I was A column of Sephadex G-100 (1.2x 100cm) which was equilibrated with 0. 03 m phospate buffer containing 0.3m NaCl (pH 7.5), was developed with the same buffer. The flow rate was 15ml/hr and peaks of each protein was determined by absorbancy at 280mp.
recognized.
The conversion of II to I involves the dehydrogenation of -GH-NH-to -ONgroup.
Therefore, the enzyme SF-973 B is an oxidoreductase, and may be named dihydroabikoviromycin dehydrogenase.
The enzyme SF-973 B has the maximum calalytic activity at around pH 7.0 as shown in Fig. 5 . It is stable in an aqueous solution over a pH range of 6.5~8.5 at 35°C for 20hours (Fig. 6 ), but at higher temperature such as at 80°C, the activity is almost completely lost within 10minutes, even at pH 7.0. The optimumtemperature for the catalyst was found to be relatively high, about 45-55°C (Fig.  7) .
The molecular weight of SF-973 B was estimated by gel nitration over Sephadex G-100. Fig. 8 From the calibration curve, the molecular weight was estimated to be about 36,000. phosphate buffer (pH 7) was placed in a Thunberg tube. In a sidearm was added 10mg of the enzyme SF-973 B dissolved in 3ml of the same buffer. After de-gassing by vacuum pump (10mmHg), both solutions were mixed and incubated at 30°C under the oxygen-free condition. After 2hours, the incubated solution was extracted with ethyl acetate at pH 9 and submitted to silica gel TLG. No conversion of compound ll into I was recognized. These results suggested that SF-973 B may be an enzyme catalyzing autoxidation of dihydroabikoviromycin and that the last acceptor of two hydrogens liberated in the reaction is oxygen as shown in Scheme 2. In this study, it was not possible to determine a favorable condition for the reverse hydrogenation reaction from I to II. 
